C5aR1-positive macrophage-mediated PARPi resistance can be transferred to distant sites suggesting that the ability of a tumor subclone to generate C5aR1 high macrophages could mediate resistance of normally PARPi-sensitive subclones at disparate sites in a solid tumor or potentially at metastatic tumor sites. Here, C5AR1 is linked to neoplasm.